Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Yang Y, Bailey C, Holz FG, Eter N, Weber M, Baker C et al. Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants. Eye (Lond) 2015; 29: 1173–1180.
Campochiaro PA, Brown DM, Pearson A, Ciulla T, Boyer D, Holz FG et al. Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema. Ophthalmology 2011; 118: 626–635.
Sachdev N, Ormonde SE, Sherwin T, McGhee CN . Higher-order aberrations of lenticular opacities. J Cataract Refract Surg 2004; 30: 1642–1648.
Sarao V, Veritti D, Boscia F, Lanzetta P . Intravitreal steroids for the treatment of retinal diseases. ScientificWorldJournal 2014; 2014: 989501.
Dada T, Rathi A, Angmo D, Agarwal T, Vanathi M, Khokhar SK et al. Clinical outcomes of clear lens extraction in eyes with primary angle closure. J Cataract Refract Surg 2015; 41: 1470–1477.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Takkar, B., Azad, S. Comments on 'Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants'. Eye 30, 1023 (2016). https://doi.org/10.1038/eye.2016.27
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2016.27
